| Menopausal syndrome
Bijuva vs Climara Pro
Side-by-side clinical, coverage, and cost comparison for menopausal syndrome.Deep comparison between: Bijuva vs Climara Pro with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsClimara Pro has a higher rate of injection site reactions vs Bijuva based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Climara Pro but not Bijuva, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Bijuva
Climara Pro
At A Glance
Oral
Daily
Estrogen-progesterone combination
Transdermal patch
Weekly
Estrogen/progestogen combination
Indications
- Menopausal syndrome
- Menopausal syndrome
- Osteoporosis, Postmenopausal
Dosing
Menopausal syndrome Start with 0.5 mg estradiol/100 mg progesterone orally once each evening with food; adjust dose based on clinical response; attempt to taper or discontinue at 3 to 6 month intervals.
Menopausal syndrome, Osteoporosis, Postmenopausal 0.045 mg estradiol/0.015 mg levonorgestrel per day applied transdermally once weekly; for vasomotor symptoms, attempts to discontinue should be made at 3 to 6 month intervals.
Contraindications
- Abnormal genital bleeding of unknown etiology
- Breast cancer or history of breast cancer
- Estrogen-dependent neoplasia
- Active deep vein thrombosis (DVT), pulmonary embolism (PE), or history of these conditions
- Active arterial thromboembolic disease (stroke, myocardial infarction) or history of these conditions
- Known anaphylactic reaction, angioedema, or hypersensitivity to BIJUVA
- Hepatic impairment or disease
- Known thrombophilic disorders, such as protein C, protein S, or antithrombin deficiency
- Undiagnosed abnormal genital bleeding
- Breast cancer or history of breast cancer
- Estrogen-dependent neoplasia
- Active DVT, PE, or a history of these conditions
- Active arterial thromboembolic disease (e.g., stroke or MI), or a history of these conditions
- Known anaphylactic reaction, angioedema, or hypersensitivity to Climara Pro
- Hepatic impairment or disease
- Protein C, protein S, or antithrombin deficiency, or other thrombophilic disorders
Adverse Reactions
Most common (>=3%) Breast tenderness, headache, nausea, vaginal bleeding, vaginal discharge, pelvic pain
Serious Cardiovascular disorders, malignant neoplasms
Postmarketing Abdominal pain, abdominal distention, diarrhea, vomiting, fatigue, malaise, weight increased, fluid retention, muscle spasms, pain in extremity, dizziness, somnolence, insomnia, sleep disorder, breast pain, uterine bleeding, night sweats, pruritus, hot flush
Most common (>3%) Application site reaction, vaginal bleeding, breast pain, upper respiratory infection, back pain, depression, headache, pain, flu syndrome, abdominal pain, arthralgia, edema, flatulence, hypertension, bronchitis, sinusitis, urinary tract infection
Serious Cardiovascular disorders, malignant neoplasms
Postmarketing Changes in bleeding patterns, abdominal distension, abdominal pain, nausea, alopecia, night sweats, pruritus, rash, hot flush, dizziness, headache, insomnia, application site reaction, weight increased, anaphylactic reaction
Pharmacology
Estrogen-progesterone combination; estradiol binds nuclear estrogen receptors to reduce elevated gonadotropin levels and maintain secondary sexual characteristics in postmenopausal women, while progesterone binds progesterone receptors to transform proliferative endometrium into secretory endometrium and oppose estrogen actions.
Estrogen/progestogen combination; estradiol binds nuclear estrogen receptors in estrogen-responsive tissues to reduce elevated postmenopausal gonadotropin levels, while levonorgestrel inhibits gonadotropin production and counteracts the proliferative effects of estrogen on the endometrium.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Bijuva
- Covered on 5 commercial plans
- PA (2/12) · Step Therapy (0/12) · Qty limit (4/12)
Climara Pro
- Covered on 5 commercial plans
- PA (4/12) · Step Therapy (0/12) · Qty limit (9/12)
UnitedHealthcare
Bijuva
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Climara Pro
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (6/8)
Humana
Bijuva
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (2/3)
Climara Pro
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (2/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Bijuva.
No savings programs available for Climara Pro.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
BijuvaView full Bijuva profile
Climara ProView full Climara Pro profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.